Future therapeutics for osteoarthritis

J Martel-Pelletier, LM Wildi, JP Pelletier - Bone, 2012 - Elsevier
Osteoarthritis (OA) is a disease of the joints that affects several million individuals worldwide.
This disease, which involves mainly the diarthrodial joints, is chronic and develops slowly …

[HTML][HTML] New trends in pharmacological treatments for osteoarthritis

X Cai, S Yuan, Y Zeng, C Wang, N Yu… - Frontiers in …, 2021 - frontiersin.org
Osteoarthritis (OA) is the leading cause of function loss and disability among the elderly, with
significant burden on the individual and society. It is a severe disease for its high disability …

[HTML][HTML] The future of osteoarthritis therapeutics: targeted pharmacological therapy

A Mobasheri - Current rheumatology reports, 2013 - Springer
Osteoarthritis (OA) is one of the most common forms of degenerative joint disease and a
major cause of pain and disability affecting the aging population. It is estimated that more …

Update on novel pharmacological therapies for osteoarthritis

A Ghouri, PG Conaghan - Therapeutic advances in …, 2019 - journals.sagepub.com
Osteoarthritis (OA) is a chronic painful arthritis with increasing global prevalence. Current
management involves non-pharmacological interventions and commonly used …

Emerging drugs for osteoarthritis

GL Matthews, DJ Hunter - Expert opinion on emerging drugs, 2011 - Taylor & Francis
Introduction: Osteoarthritis (OA), the most prevalent form of joint disease, affects as much as
13% of the world's population. In the USA, it is the leading cause of disability in people over …

Emerging pharmaceutical therapies for osteoarthritis

A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …

Investigational drugs for the treatment of osteoarthritis, an update on recent developments

Z Zhu, J Li, G Ruan, G Wang, C Huang… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Osteoarthritis (OA) is the leading cause of pain, loss of function, and disability
among elderly, with the knee the most affected joint. It is a heterogeneous condition …

[HTML][HTML] New drug treatments for osteoarthritis: what is on the horizon?

FE Watt, M Gulati - European medical journal. Rheumatology, 2017 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is the most common form of arthritis, yet has historically lagged far behind
rheumatoid arthritis in terms of drug development. Despite the many challenges presented …

Current treatment options for osteoarthritis

W Hermann, S Lambova… - Current rheumatology …, 2018 - ingentaconnect.com
Osteoarthritis (OA) is the most common joint disease and a leading cause for impaired
function and disability with significant treatment costs and socio-economic burden. Despite …

[HTML][HTML] Prospects for therapies in osteoarthritis

A Ghouri, PG Conaghan - Calcified tissue international, 2021 - Springer
Osteoarthritis (OA) is a chronic, debilitating disease affecting millions of people worldwide.
Management of OA involves pharmacological and non-pharmacological approaches …